December 2025 in “Cureus” This source details the process necessary to substantiate "clinically proven" claims for products, emphasizing the importance of rigorous clinical trials, regulatory compliance, and emerging technologies in ensuring safety, efficacy, and credibility across diverse populations and settings.
December 2025 in “Journal of Education Health and Sport” This review discusses the potential of green tea, especially its catechin EGCG, in reducing PCOS symptoms like insulin resistance and androgen levels, but reports no new clinical results and emphasizes the need for further research.
April 2025 in “National Journal of Medical Research” This observational study conducted in an Indian hospital found that autoimmune conditions, particularly alopecia areata, were the most prevalent scalp dermatoses among 152 patients, emphasizing the importance of accurate diagnosis and treatment to address both physical and psychological impacts.
December 2024 in “International Journal of experimental research and review” In this study, the integration of obesity-related features and machine learning techniques significantly enhanced cardiovascular disease detection, with the XGBoost classifier achieving a 74% accuracy rate and improved metrics compared to other models.
December 2024 in “African Journal of Biomedical Research” This study reported that the combined use of dexmedetomidine and ketamine, along with peripheral nerve blocks, provided adequate sedation and analgesia with maintained hemodynamic stability in patients undergoing minor surgical procedures like split skin grafting.
Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.
In this integrative review, researchers assessed the efficacy of oral minoxidil for treating alopecia, finding that it appears effective, especially for female androgenetic alopecia, though evidence quality is very low and side effects limit its use compared to topical forms.
January 2024 in “International Journal of Health Science” This study evaluated emerging techniques for managing chemotherapy-induced alopecia and found that scalp cooling significantly reduced hair loss, while photobiomodulation was well-tolerated without major adverse effects; however, further research is needed to refine treatment protocols and ensure long-term safety.
This congress summary highlights the COMEF 2023 event, which focused on medical ethics, education, and health through discussions with the theme "Learn, practice, excel," but reports no new research findings.
January 2024 in “Polski Merkuriusz Lekarski” This retrospective cross-section study found that in a cohort of Pica patients in Iraq, 92.4% were female, and many had low levels of ferritin, hemoglobin, and vitamin D, which may contribute to the disorder by causing psychological issues.
December 2023 in “Health economics and management review” In this descriptive research conducted in Tirunelveli City, Tamil Nadu, the study identified common health problems among radiographers, including tiredness, body pain, and emotional disturbances, highlighting the need to address these issues to ensure accurate disease diagnosis and treatment in healthcare settings.
September 2023 in “International journal of medicine” This study reviewed the current status and future scope of artificial intelligence in healthcare, highlighting its potential to revolutionize medical practices through improved affordability, efficiency, and speed, as well as its applicability in various fields such as imaging, diagnosis, and individualized care.
August 2023 in “Jurnal Pharmacia Mandala Waluya” This study examined the effects of purified Albizia saponaria bark extract on hair growth in rabbits, finding that a 20% concentration of the extract increased hair weight significantly, though it was less effective than minoxidil.
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
January 2023 in “Book of Abstracts” COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.
December 2022 in “Otorhinolaryngology, Head and Neck Pathology.” This study found that applying photobiomodulation therapy after septoplasty helped reduce pain and mitigate changes in the autonomic nervous system compared to those who did not receive the therapy.
December 2022 in “Otorhinolaryngology, Head and Neck Pathology.” In this study, the combination of photobiomodulation therapy and Respiro Myrtol forte reduced pain and inflammation more effectively than either treatment alone in patients after septoplasty.
November 2022 in “Innovation in aging” This study reports that hair cortisol measurement in older Puerto Rican adults found a significant portion had non-detectable cortisol levels, especially among black participants, influencing exclusion rates in such populations.
May 2022 in “Голова и шея.” In this pilot study, researchers observed that low-intensity laser radiation at 445±40 nm increased the temperature of gingival tissues in Wistar rats by 8.37°C without exceeding the safety threshold, suggesting potential for clinical trials.
May 2022 in “Голова и шея.” In this study, the transition from online to full-time education was associated with a worsened emotional state among students, despite already impaired biorhythm indicators during online classes.
May 2022 in “Голова и шея.” This narrative review discusses the challenges and special care needs of laryngectomy patients with tracheoesophageal bypass during the COVID-19 pandemic and reports no new clinical results.
May 2022 in “Голова и шея.” This study examined how a developed distance program of physical education classes affected the cardio-respiratory system of students in a special medical department.
May 2022 in “Голова и шея.” This review discusses the hypothesis of supranormal adaptation related to the evolution of the distal radius and wrist anatomy, reporting no new experimental findings.
May 2022 in “Голова и шея.” This study observed that, in rats, modeling sinus lifting and septoplasty led to increased sympathetic nervous system activity and metabolic shifts in the early postoperative period due to inflammation.
May 2022 in “Голова и шея.” This article highlights exosome-based targeted drug delivery using DARPin G3 proteins as a promising approach for treating aggressive HER2-positive breast cancer but reports no new clinical results.
May 2022 in “Голова и шея.” In this study, managing laryngectomy patients during the COVID-19 pandemic requires special precautions due to their unique respiratory challenges, emphasizing the need for protective equipment and postponement of non-essential procedures to reduce infection risks for patients and health care providers.
May 2022 in “Голова и шея.” This study found a direct correlation between chronic tonsillitis and increased NETosis activity in peripheral blood and palatine tonsil lacunae.
May 2022 in “Голова и шея.” The study found that experimental inflammation from nasal septum surgery in rats caused a shifts in autonomic nervous system balance, with sympathetic dominance and parasympathetic suppression, normalizing after one week.
May 2022 in “Голова и шея.” This study revealed that dentists in a surveyed Russian region showed low awareness of the potential link between vitamin D3 deficiency and complications in dental implantation.
May 2022 in “Голова и шея.” This study observed that elderly women exhibited a tendency for higher personal anxiety and increased brain DC-potential indicators, with distinct energy cost patterns in different brain regions compared to elderly men.